Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | KIF11 | P52732 | 3/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.43 |
| ▸ | AGXT | P21549 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1465632 | 0.80 | ALDH1A1 (0.48) | CA1CA2KIF11KCNH2TAAR1 | |
| SCHEMBL989033 | 0.80 | TAAR1 (0.56) | CA1CA2CA12CA7CA9 | |
| Hydrochloric Acid SCHEMBL8506781 | 0.78 | TAAR1 (0.54) | CA1CA2CA12CA7CA9 | |
| SCHEMBL3152160 | 0.78 | CA1 (0.58) | CA1CA2CA12CA7CA9 | |
| SCHEMBL15552915 | 0.78 | KIF11 (0.53) | CA1CA2CA7CA9KIF11 | |
| SCHEMBL6456115 | 0.78 | SLC6A4 (0.43) | CA1CA2CA12CA7CA9 | |
| SCHEMBL5187903 | 0.77 | AOC3 (0.64) | CA1CA2CA12CA7CA9 | |
| SCHEMBL8508653 | 0.77 | KIF11 (0.45) | CA1CA2CA12CA7CA9 | |
| SCHEMBL7043985 | 0.76 | CA1 (0.55) | CA1CA2CA12CA7CA9 | |
| SCHEMBL3799108 | 0.76 | CA1 (0.55) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311975-A1 | CATIONIC TRANSITION METAL CATALYSTS | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2010-12-09 | — | — | US | claimed |
| EP-2215101-A1 | CATIONIC TRANSITION METAL CATALYSTS | Kanata Chemical Technologies Inc. (CA) | 2010-08-11 | — | — | EP | claimed |
| WO-2009055912-A1 | CATIONIC TRANSITION METAL CATALYSTS | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2009-05-07 | — | — | WO | claimed |
| CN-112663168-B | Spandex fiber with reversible shape memory effect and preparation method and application thereof | 五邑大学 | 2022-07-19 | — | — | CN | disclosed |
| CN-112962165-B | Spandex fiber with reversible three-shape memory effect and preparation method and application thereof | 五邑大学 | 2022-07-05 | — | — | CN | disclosed |
| US-20220169600-A1 | METHOD FOR PRODUCING PKROSTAGLANDIN | KYOWA PHARMA CHEMICAL CO., LTD. (JP) | 2022-06-02 | — | — | US | disclosed |
| EP-3950672-A1 | METHOD FOR PRODUCING PKROSTAGLANDIN | Kyowa Pharma Chemical Co., Ltd. (JP) | 2022-02-09 | — | — | EP | disclosed |
| CN-112962165-A | Spandex fiber with reversible three-shape memory effect and preparation method and application thereof | 五邑大学 | 2021-06-15 | — | — | CN | disclosed |
| CN-112663168-A | Spandex fiber with reversible shape memory effect and preparation method and application thereof | 五邑大学 | 2021-04-16 | — | — | CN | disclosed |
| US-10189871-B2 | Transition metal complexes for enantioselective catalysis of carbon-carbon, carbon-heteroatom, and carbon-hydrogen bond forming reactions | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2019-01-29 | — | — | US | disclosed |
| CN-101730656-B | Method for the production of hydrogen from ammonia borane | 卡娜塔化学技术股份有限公司 | 2017-05-03 | — | — | CN | disclosed |
| WO-2009055912-A1 | CATIONIC TRANSITION METAL CATALYSTS | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2009-05-07 | — | — | WO | disclosed |
| WO-2008141439-A1 | METHOD FOR THE PRODUCTION OF HYDROGEN FROM AMMONIA BORANE | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2008-11-27 | — | — | WO | disclosed |
| EP-1765833-A2 | NEWS SALTS IN THE PREPARATION OF CEPHALOSPORIN ANTIBIOTICS | Orchid Chemicals and Pharmaceuticals Limited (IN) | 2007-03-28 | — | — | EP | disclosed |
| WO-2006006040-A2 | NEWS DIAMINE SALTS OF CEPHALOSPORIN ANTIBIOTICS AND THEIR PREPARATION | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2006-01-19 | — | — | WO | disclosed |
| US-6878838-B2 | Chiral porous metal phosphonates for heterogeneous asymmetric catalysis | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2005-04-12 | — | — | US | disclosed |
| WO-2004084834-A2 | CHIRAL POROUS METAL PHOSPHONATES FOR HETEROGENEOUS ASYMMETRIC CATALYSIS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2004-10-07 | — | — | WO | disclosed |
| US-20040192543-A1 | Chiral porous metal phosphonates for heterogeneous asymmetric catalysis | NORTH CAROLINA AT CHAPEL HILL, UNIVERSITY OF, THE | 2004-09-30 | — | — | US | disclosed |
| US-20030045727-A1 | Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2003-03-06 | — | — | US | disclosed |
| EP-1254885-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE SECONDARY ALCOHOLS HAVING NITROGENOUS OR OXYGENIC FUNCTIONAL GROUPS | Asahi Kasei Kabushiki Kaisha (JP) | 2002-11-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10189871-B2 | Transition metal complexes for enantioselective catalysis of carbon-carbon, carbon-heteroatom, and carbon-hydrogen bond forming reactions | SOD1, YWHAZ, L1CAM | CA1 161/4885CA2 172/4885CA12 452/4885 |
| US-20220169600-A1 | METHOD FOR PRODUCING PKROSTAGLANDIN | PTGS1, PTGER1, RACK1 | CA1 2612/4885CA2 1309/4885CA12 4438/4885 |
| US-20030045727-A1 | Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups | ADH1A, ADH5, ADH1C | CA1 2203/4885CA2 1237/4885CA12 2030/4885 |
| US-20100311975-A1 | CATIONIC TRANSITION METAL CATALYSTS | AP2M1, OPRM1, CD81 | CA1 2319/4885CA2 1025/4885CA12 2196/4885 |
| US-20040192543-A1 | Chiral porous metal phosphonates for heterogeneous asymmetric catalysis | ZKSCAN2, TPRKB, KHK | CA1 307/4885CA2 459/4885CA12 720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.